MENU

TARA Protara Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TARA is expected to report earnings to rise 15.34% to -57 cents per share on March 05

Protara Therapeutics TARA Stock Earnings Reports
Q4'24
Est.
$-0.58
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.29
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.02
The last earnings report on November 12 showed earnings per share of -50 cents, beating the estimate of -51 cents. With 771.25K shares outstanding, the current market capitalization sits at 192.88M.
A.I. Advisor
published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 646 844-0337
Employees
27
Web
http://www.protaratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

TARA and Stocks

Correlation & Price change

A.I.dvisor tells us that TARA and CDIO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and CDIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+1.63%
CDIO - TARA
31%
Poorly correlated
-24.11%
DNA - TARA
26%
Poorly correlated
+1.91%
VERA - TARA
26%
Poorly correlated
-0.11%
ZLAB - TARA
24%
Poorly correlated
+3.02%
VIR - TARA
24%
Poorly correlated
-2.78%
More